You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR FETZIMA

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for FETZIMA

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02265367 ↗	Novel Medication as a Potential Smoking Cessation Aid	Completed	University of Minnesota	Early Phase 1	2015-01-01	The purpose of this study is to provide preliminary information assessing if levomilnacipran may be effective at increasing smoking cessation rates.
NCT02265367 ↗	Novel Medication as a Potential Smoking Cessation Aid	Completed	University of Minnesota - Clinical and Translational Science Institute	Early Phase 1	2015-01-01	The purpose of this study is to provide preliminary information assessing if levomilnacipran may be effective at increasing smoking cessation rates.
NCT02288325 ↗	A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder	Completed	Forest Laboratories	Phase 4	2014-11-18	This study evaluates the efficacy, safety and tolerability of levomilnacipran extended-release (ER) compared with placebo in the prevention of depression relapse in major depressive disorder (MDD).
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for FETZIMA

Condition Name

Chart
Table

Condition Name for FETZIMA
Intervention	Trials
Major Depressive Disorder	4
Depressive Disorder, Major	1
Major Depressive Disorder (MDD)	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for FETZIMA
Intervention	Trials
Depressive Disorder, Major	5
Depressive Disorder	5
Depression	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for FETZIMA

Trials by Country

Map
Table

Trials by Country for FETZIMA
Location	Trials
United States	50
Canada	1
Puerto Rico	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for FETZIMA
Location	Trials
Georgia	3
California	3
Virginia	2
Texas	2
Tennessee	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for FETZIMA

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for FETZIMA
Clinical Trial Phase	Trials
Phase 4	4
Phase 3	2
Early Phase 1	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for FETZIMA
Clinical Trial Phase	Trials
Completed	5
Active, not recruiting	1
Recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for FETZIMA

Sponsor Name

Chart
Table

Sponsor Name for FETZIMA
Sponsor	Trials
Forest Laboratories	3
Duke University	1
National Institute of Mental Health (NIMH)	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for FETZIMA
Sponsor	Trials
Other	9
Industry	4
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.